Drug Shortage Report for EXTAVIA

Last updated on 2019-12-13 History
Report ID 100125
Drug Identification Number 02337819
Brand name EXTAVIA
Common or Proper name EXTAVIA 30G/VIAL 0.3MG (X15)
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Active Ingredient(s) INTERFERON BETA-1B
Strength(s) 0.3MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS
Packaging size X15
ATC code L03AB
ATC description IMMUNOSTIMULANTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-12-12
Actual start date
Estimated end date 2020-02-03
Actual end date
Shortage status Actual shortage
Updated date 2019-12-13
Company comments
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2019-12-13 English Compare
v2 2019-12-03 French Compare
v1 2019-12-03 English Compare